• Expert Rev Clin Pharmacol · Jan 2015

    Editorial

    Factors to consider in the choice of intrathecal drug in the treatment of neuropathic pain.

    • Timothy R Deer and Jason E Pope.
    • a 1 CEO Center for pain relief, Charleston, WV, USA.
    • Expert Rev Clin Pharmacol. 2015 Jan 1; 8 (5): 507-10.

    AbstractMedication selection for neuropathic pain follows a path of evidence, with respect to appreciating the patient's entry into the pain care algorithm. As we decide how to approach neuropathic pain, the considerations for intrathecal therapy medication selection are bound by catheter location, region of pain, and patient selection, to name a few. Future research and the 2016 polyanalgesic consensus conference may further provide patient care through a mindful eye on the improvement of patient safety and a reduction of the societal needs of opioids.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,694,794 articles already indexed!

We guarantee your privacy. Your email address will not be shared.